LBBW Aktienanleihe FRE 24.01.2025/ DE000LB4UX29 /
1/8/2025 5:15:13 PM | Chg.-0.010 | Bid1/8/2025 | Ask1/8/2025 | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
100.020EUR | -0.01% | - Bid Size: - |
- Ask Size: - |
FRESENIUS SE+CO.KGAA... | 21.00 - | 1/24/2025 | Call |
GlobeNewswire
4/24/2024
Travere Therapeutics and CSL Vifor Announce European Commission Approves FILSPARI® (sparsentan) for ...
GlobeNewswire
4/23/2024
Transferring Biomedical Research to Patients Faster: ForTra gGmbH Announces Positive Funding Track R...
GlobeNewswire
2/23/2024
Travere Therapeutics and CSL Vifor Announce Sparsentan Receives Positive CHMP Opinion for the Treatm...
GlobeNewswire
9/4/2023
CIO Leadership: Generative AI and Visionary Leadership in the Enterprise Will Power the Discussion a...
GlobeNewswire
8/31/2023
CytoSorbents Granted Expanded ANVISA Registration to Treat Shock with CytoSorb in Brazil